Draft:MediFind
Healthcare search platform acquired by Phreesia
From Wikipedia, the free encyclopedia
MediFind is a U.S.-based healthcare search platform. According to Philadelphia Magazine, the platform provides tools for users to find physicians, clinical trials, and medical research related to specific conditions.[1] In 2023, MediFind was acquired by Phreesia, a healthcare software company.[3][2]
 | Review waiting, please be patient.
This may take 2 months or more, since drafts are reviewed in no specific order. There are 4,267 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 13 March 2026 by Pythoncoder (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |  |
History
MediFind was founded in February 2020 by Patrick Howie. Philadelphia Magazine reported that the company was created to help patients identify specialists and clinical trials, particularly for rare diseases.[1]
The same publication reported that in 2020 the platform expanded its coverage to include COVID-19-related information and clinical trials.[1]
Platform
According to Philadelphia Magazine, MediFind aggregates medical research and presents condition summaries intended for non-specialist readers, along with tools for identifying physicians and clinical trials.[1]
Coverage of the company’s acquisition described MediFind as using machine learning and analytics to help connect patients with care options, particularly for serious and chronic conditions.[3]
Healthcare IT Today described MediFind as using algorithms and data analysis to evaluate medical information and help identify physicians with expertise in specific conditions.[4]
Acquisition by Phreesia
Phreesia announced in July 2023 that it had acquired MediFind.[3] According to a filing with the U.S. Securities and Exchange Commission, the transaction was structured as a merger in which Comsort, Inc., operating as MediFind, became a wholly owned subsidiary of Phreesia, with the deal closing on June 30, 2023.[2] The filing reported total consideration of approximately $9 million, consisting of cash and stock and subject to customary adjustments.[2]
LLM-generated pages with the below issues may be deleted without notice.
These tools are prone to specific issues that violate our policies:
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject.
See the advice page on large language models for more information.